These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3196378)

  • 1. Use of the novel cardiotonic and vasodilator agent pimobendan in traumatic shock.
    Bitterman H; Smith BA; Lefer AM
    Arzneimittelforschung; 1988 Oct; 38(10):1389-93. PubMed ID: 3196378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-shock actions of the pyrimido-pyrimidine derivative, RA-642.
    Hock CE; Lefer DJ; Lefer AM
    Methods Find Exp Clin Pharmacol; 1986 May; 8(5):265-9. PubMed ID: 3724301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial actions of BN 50739, a new PAF receptor antagonist, in murine traumatic shock.
    Karasawa A; Rochester JA; Lefer AM
    Methods Find Exp Clin Pharmacol; 1990 May; 12(4):231-7. PubMed ID: 2165204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of two leukotriene antagonists in rat traumatic shock.
    Levitt MA; Lefer AM
    Methods Find Exp Clin Pharmacol; 1987 May; 9(5):269-73. PubMed ID: 3613754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of a combination thromboxane synthesis inhibitor-receptor antagonist, R-68070, during murine traumatic shock.
    Aoki N; Johnson G; Siegfried MR; Lefer AM
    Eicosanoids; 1989; 2(3):169-74. PubMed ID: 2534278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of a new LTD4 antagonist (LY-171883) in traumatic shock.
    Hock CE; Lefer AM
    Circ Shock; 1985; 17(4):263-72. PubMed ID: 3841503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effect of a thromboxane synthetase inhibitor in traumatic shock.
    Hock CE; Lefer AM
    Circ Shock; 1984; 14(3):159-68. PubMed ID: 6542462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial actions of antagonism of peptide leukotrienes in hemorrhagic shock.
    Bitterman H; Smith BA; Lefer AM
    Circ Shock; 1988 Mar; 24(3):159-68. PubMed ID: 3383353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of adenosine, an adenosine-A1 antagonist, and their combination in splanchnic occlusion shock in rats.
    Karasawa A; Rochester JA; Lefer AM
    Circ Shock; 1992 Feb; 36(2):154-61. PubMed ID: 1582007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac electrophysiologic and hemodynamic activity of pimobendan (UD-CG 115 BS), a new inotropic agent.
    Kitzen JM; Lynch JJ; Driscoll EM; Lucchesi BR
    J Pharmacol Exp Ther; 1988 Mar; 244(3):929-39. PubMed ID: 3252039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of oligotide, a novel oligodeoxyribonucleotide, in murine traumatic shock.
    Skurk C; Nuss C; Lefer AM
    Shock; 1995 Jan; 3(1):13-20. PubMed ID: 7531603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of prostaglandin E1 infusion in experimental traumatic shock.
    Levitt MA; Lefer AM
    Crit Care Med; 1987 Aug; 15(8):769-73. PubMed ID: 3608533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-shock properties of the prostacyclin analog, iloprost, in traumatic shock.
    Levitt MA; Lefer AM
    Prostaglandins Leukot Med; 1986 Dec; 25(2-3):175-85. PubMed ID: 2434958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial actions of RO 15-1788, a benzodiazepine receptor antagonist, in hemorrhagic shock.
    Bitterman H; Lefer DJ; Lefer AM
    Methods Find Exp Clin Pharmacol; 1987 Jun; 9(6):341-7. PubMed ID: 3116357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salutary effects of anisodamine in murine traumatic shock.
    Hock CE; Su JY; Lefer AM
    Circ Shock; 1983; 11(3):211-6. PubMed ID: 6652878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salutary effects of CG-4203, a novel, stable prostacyclin analog, in hemorrhagic shock.
    Bitterman H; Smith BA; Lefer DJ; Lefer AM
    J Cardiovasc Pharmacol; 1988 Sep; 12(3):293-9. PubMed ID: 2464101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of CG-4203, a novel stable prostacyclin analog, in traumatic shock.
    Bitterman H; Stahl GL; Lefer AM
    Prostaglandins; 1988 Jan; 35(1):41-50. PubMed ID: 3287456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective actions of nafazatrom in traumatic shock.
    Lefer AM; Messenger M
    Arzneimittelforschung; 1982; 32(9):1089-91. PubMed ID: 6890831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a combination thromboxane receptor antagonist and lipoxygenase inhibitor in traumatic shock.
    Levitt MA; Stahl G; Lefer AM
    Resuscitation; 1988 Jul; 16(3):211-20. PubMed ID: 2845544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular pharmacology of 6-[4-(4'-pyridyl)aminophenyl]-4,5-dihydro-3(2H)-pyridazinone hydrochloride, a novel and potent cardiotonic agent with vasodilator properties.
    Narimatsu A; Kitada Y; Satoh N; Suzuki R; Okushima H
    Arzneimittelforschung; 1987 Apr; 37(4):398-406. PubMed ID: 3606694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.